BR9914044A - ésteres tetrahidropirido - Google Patents

ésteres tetrahidropirido

Info

Publication number
BR9914044A
BR9914044A BR9914044-6A BR9914044A BR9914044A BR 9914044 A BR9914044 A BR 9914044A BR 9914044 A BR9914044 A BR 9914044A BR 9914044 A BR9914044 A BR 9914044A
Authority
BR
Brazil
Prior art keywords
esters
tetrahydropyride
tetrahydropirid
substituents
prevention
Prior art date
Application number
BR9914044-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Joerg Senn-Bilfinger
Stefan Postius
Wolfgang-Alexander Simon
Erhard Grundler
Guido Hanauer
Reinhard Huber
Wolfgangkromer
Ernst Sturm
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of BR9914044A publication Critical patent/BR9914044A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR9914044-6A 1998-09-23 1999-09-17 ésteres tetrahidropirido BR9914044A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19843504 1998-09-23
EP98117988 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (1)

Publication Number Publication Date
BR9914044A true BR9914044A (pt) 2001-12-04

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914044-6A BR9914044A (pt) 1998-09-23 1999-09-17 ésteres tetrahidropirido

Country Status (31)

Country Link
US (4) US6436953B1 (https=)
EP (1) EP1115725B1 (https=)
JP (1) JP4145492B2 (https=)
KR (1) KR100668400B1 (https=)
CN (2) CN1155598C (https=)
AT (1) ATE231862T1 (https=)
AU (1) AU763463B2 (https=)
BG (1) BG65195B1 (https=)
BR (1) BR9914044A (https=)
CA (1) CA2344251A1 (https=)
CZ (1) CZ292335B6 (https=)
DE (1) DE69905178T2 (https=)
DK (1) DK1115725T3 (https=)
EA (1) EA005377B1 (https=)
EE (1) EE04677B1 (https=)
ES (1) ES2191464T3 (https=)
GE (1) GEP20032926B (https=)
HK (1) HK1038360B (https=)
HR (1) HRP20010224A2 (https=)
HU (1) HUP0102990A3 (https=)
ID (1) ID28896A (https=)
IL (2) IL142063A0 (https=)
NO (1) NO317304B1 (https=)
NZ (1) NZ510610A (https=)
PL (1) PL193616B1 (https=)
PT (1) PT1115725E (https=)
RS (1) RS50145B (https=)
SI (1) SI1115725T1 (https=)
SK (1) SK285165B6 (https=)
TR (1) TR200100805T2 (https=)
WO (1) WO2000017200A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436953B1 (en) * 1998-09-23 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
WO2000063211A1 (en) * 1999-04-17 2000-10-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Haloalkoxy imidazonaphthyridines
CA2285516C (en) * 1999-05-12 2010-12-07 President And Fellows Of Harvard College Dopamine transporter imaging agents
CA2404477A1 (en) * 2000-03-29 2001-10-04 Altana Pharma Ag Tricyclic imidazopyridines
SK286850B6 (sk) * 2000-03-29 2009-06-05 Altana Pharma Ag Prekurzory imidazopyridínových derivátov, farmaceutický prostriedok s ich obsahom a ich použitie
EA008151B1 (ru) * 2000-10-25 2007-04-27 Алтана Фарма Аг Полизамещенные имидазопиридины в качестве ингибиторов желудочной секреции
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MXPA03007888A (es) * 2001-03-08 2003-12-04 Astrazeneca Ab Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
HUP0400379A3 (en) 2001-08-02 2007-10-29 Altana Pharma Ag Tricyclic epoxides and their use for the preparation of pharmaceutically active agents
PL368586A1 (en) * 2001-08-03 2005-04-04 Altana Pharma Ag Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
US20040235882A1 (en) * 2001-08-03 2004-11-25 Jorg Senn-Bilfinger Amino-substituted imidazopyridines for the treatment of gastrointestial diseases
US7314935B2 (en) 2002-02-15 2008-01-01 Altana Pharma Ag Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
RS95304A (sr) * 2002-05-07 2006-12-15 Altana Pharma Ag. Nova kombinacija za tretman oboljenja disajnih puteva
AU2003288071A1 (en) 2002-11-19 2004-06-15 Altana Pharma Ag 8-substituted imidazopyridines
US7879833B2 (en) 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
HRP20050632A2 (hr) * 2002-12-20 2006-04-30 Altana Pharma Ag Silil eteri
MXPA05008490A (es) * 2003-02-17 2005-10-18 Altana Pharma Ag Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias.
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
WO2004105795A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
KR20060118421A (ko) * 2003-08-29 2006-11-23 다이노젠 파마세우티컬스, 인코포레이티드 위장 운동 장애의 치료에 유용한 조성물
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
KR20060099524A (ko) * 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-a]피리딘유도체
WO2005058894A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
CA2579127C (en) 2004-09-03 2011-08-02 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-c]피리딘 유도체 및 그의 제조방법
ATE518858T1 (de) 2004-09-03 2011-08-15 Yuhan Corp Pyrroloä3,2-cüpyridinderivate und herstellungsverfahren dafür
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
KR101605063B1 (ko) * 2009-07-09 2016-03-21 라퀄리아 파마 인코포레이티드 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
JP6001168B2 (ja) * 2012-06-15 2016-10-05 バイオ‐ファーム ソリューションズ カンパニー リミテッドBio‐Pharm Solutions Co., Ltd. フェニルアルキルスルファメート化合物及びこれを含む筋弛緩剤組成物
EP3054949A1 (en) 2013-10-08 2016-08-17 Katairo GmbH Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
WO1989000570A1 (fr) * 1987-07-16 1989-01-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux diazoles
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
EP0773945A1 (de) * 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Acylimidazopyridine
EP0971922B1 (en) * 1997-03-24 2004-04-28 ALTANA Pharma AG Tetrahydropyrido compounds
EA002402B1 (ru) * 1997-03-24 2002-04-25 Бык Гульден Ломберг Хемише Фабрик Гмбх Тетрагидропиридо-соединения
US6436953B1 (en) 1998-09-23 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers

Also Published As

Publication number Publication date
US20020169320A1 (en) 2002-11-14
SK3992001A3 (en) 2001-12-03
PL193616B1 (pl) 2007-02-28
JP4145492B2 (ja) 2008-09-03
ES2191464T3 (es) 2003-09-01
KR20010075223A (ko) 2001-08-09
JP2002526499A (ja) 2002-08-20
HK1038360B (en) 2003-05-16
DE69905178D1 (de) 2003-03-06
PL346617A1 (en) 2002-02-25
US6696460B2 (en) 2004-02-24
YU21401A (sh) 2004-03-12
ID28896A (id) 2001-07-12
NO317304B1 (no) 2004-10-04
RS50145B (sr) 2009-03-25
AU6192099A (en) 2000-04-10
EA005377B1 (ru) 2005-02-24
CN1155598C (zh) 2004-06-30
HRP20010224A2 (en) 2002-04-30
KR100668400B1 (ko) 2007-01-17
CN100506821C (zh) 2009-07-01
ATE231862T1 (de) 2003-02-15
GEP20032926B (en) 2003-03-25
BG105270A (en) 2001-11-30
CZ292335B6 (cs) 2003-09-17
US20040162310A1 (en) 2004-08-19
CN1319101A (zh) 2001-10-24
EP1115725B1 (en) 2003-01-29
DE69905178T2 (de) 2003-07-17
EP1115725A1 (en) 2001-07-18
IL142063A0 (en) 2002-03-10
NO20011243D0 (no) 2001-03-12
EE04677B1 (et) 2006-08-15
US7393860B1 (en) 2008-07-01
EE200100172A (et) 2002-06-17
SK285165B6 (sk) 2006-07-07
NO20011243L (no) 2001-03-12
CA2344251A1 (en) 2000-03-30
NZ510610A (en) 2003-07-25
IL142063A (en) 2007-10-31
BG65195B1 (bg) 2007-06-29
HUP0102990A2 (hu) 2002-01-28
SI1115725T1 (en) 2003-06-30
EA200100315A1 (ru) 2001-10-22
PT1115725E (pt) 2003-06-30
AU763463B2 (en) 2003-07-24
WO2000017200A1 (en) 2000-03-30
HUP0102990A3 (en) 2002-09-30
US6436953B1 (en) 2002-08-20
TR200100805T2 (tr) 2001-08-21
CN1560055A (zh) 2005-01-05
HK1038360A1 (en) 2002-03-15
CZ20011082A3 (cs) 2001-09-12
US7105676B2 (en) 2006-09-12
DK1115725T3 (da) 2003-06-23

Similar Documents

Publication Publication Date Title
BR9914044A (pt) ésteres tetrahidropirido
BR0012666A (pt) Imidazoimidazóis e triazóis como agentes anti-inflamatórios
ATE253063T1 (de) 5-ht1f-agonisten
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
BR9900443A (pt) Esteres de ácido aril acrìlico.
DK0705100T3 (da) Terapeutiske substituerede guanidiner
ATE386742T1 (de) Imidazonaphthyridine
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
DK0971922T3 (da) Tetrahydropyrido-forbindelser
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
SE9801494D0 (sv) Novel use
ID25478A (id) Agonis 5-ht1f
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
PE61999A1 (es) Compuestos de tetrahidropiridina
DK1551850T3 (da) 2"-oxo-voruscharin og derivater deraf

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: C07D 471/14, A61K 31/435

Ipc: C07D 471/14 (2009.01), A61K 31/4375 (2009.01), A61

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11 E 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.